🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will address the question of whether targeting CMV antigens with...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2024-07-18
Trial ID
NCT05096481
Treatments Being Tested
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
Primary Objective: To demonstrate the vaccine seroresponse sufficiency of ...
Status
Completed
Location
Investigational Site Number 8400012
Start Date
2019-09-03
Trial ID
NCT04084769
This study aims to evaluate the persistence of anti-poliovirus antibodies i...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-04-25
Trial ID
NCT01323647
Treatments Being Tested
This study will be conducted in two stages. In the diphtheria, tetanus, per...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-06-16
Trial ID
NCT00228917
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
Primary objectives: To demonstrate that REPEVAX and VAXIGRIP administered ...
Status
Completed
Location
Sanofi Pasteur MSD Investigational Site
Start Date
2010-10
Trial ID
NCT01249183
Treatments Being Tested
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
The investigator is developing an immune therapy against pancreatic cancer....
Status
Terminated
Location
Albert Einstein College of Medicine
Start Date
2017-07-21
Trial ID
NCT03848182
Treatments Being Tested